Article
[Multi-classification prediction model of lung cancer tumor mutation burden based on residual network].
Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi - 25 Oct 2023
Meng Xiangfu, Yu Chunlin, Yang Xiaolin, Yang Ziyi, Liu Deng
Abstract excerpt
Medical studies have found that tumor mutation burden (TMB) is positively correlated with the efficacy of immunotherapy for non-small cell lung cancer (NSCLC), and TMB value can be used to predict the efficacy of targeted therapy and chemotherapy. However, the calculation of TMB value mainly depends on the whole exon sequencing (WES) technology, which usually costs too much time and expenses. To deal with above...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
